Is DEVLX or ABBV a better dividend investment in 2026?

DEVLX currently yields 13.34% with a 5% 5-year dividend growth rate. ABBV yields 3.67% with 8.9% growth. The better choice depends on your goal: DEVLX offers higher current income.

What is the dividend yield difference between DEVLX and ABBV?

DEVLX has a forward dividend yield of 13.34% ($8.41/share annually). ABBV yields 3.67% ($6.20/share annually). The yield gap is 9.67 percentage points.

Home › Compare › DEVLX vs ABBV

DEVLX vs ABBV: Dividend Comparison 2026

DEVLX yields 13.34% · ABBV yields 3.67%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DEVLX wins by $8.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

DEVLX

● Live price

13.34%

Share price

$63.02

Annual div

$8.41

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$48.1K

Annual income

$3,055.45

Full DEVLX calculator →

ABBV

AbbVie Inc.

● Live price

3.67%

Share price

$168.90

Annual div

$6.20

5Y div CAGR

8.9%

Payout ratio

58%

After 10 yrs · $10,000 · DRIP

Portfolio value

$39.9K

Annual income

$1,154.43

Full ABBV calculator →

Portfolio growth — DEVLX vs ABBV

📍 DEVLX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DEVLX	ABBV
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DEVLX + ABBV cover 4 of 12 months — good coverage

Jan

ABBV

Feb

—

Mar

—

Apr

ABBV

May

—

Jun

—

Jul

ABBV

Aug

—

Sep

—

Oct

ABBV

Nov

—

Dec

—

DEVLX pays

ABBV pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DEVLX

Annual income on $10K today (after 15% tax)

$1,133.97/yr

After 10yr DRIP, annual income (after tax)

$2,597.13/yr

ABBV

Annual income on $10K today (after 15% tax)

$312.02/yr

After 10yr DRIP, annual income (after tax)

$981.27/yr

At 15% tax rate, DEVLX beats the other by $1,615.87/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DEVLX + ABBV for your $10,000?

DEVLX: 50%ABBV: 50%

100% ABBV50/50100% DEVLX

Portfolio after 10yr

$44.0K

Annual income

$2,104.95/yr

Blended yield

4.78%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

DEVLX

No analyst data

ABBV

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$256.15

+51.7% upside vs current

Range: $223.00 — $299.00

Altman Z

2.0

Piotroski

8/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DEVLX buys

ABBV buys

No recent congressional trades found for DEVLX or ABBV in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDEVLXABBV

Forward yield	13.34% ✓	3.67%
Annual dividend / share	$8.41 ✓	$6.20
Payout ratio	50% ✓	58%
1-year div growth	0%	4.7% ✓
5-year div CAGR	0%	8.9% ✓
Portfolio after 10y	$48.1K ✓	$39.9K
Annual income after 10y	$3,055.45 ✓	$1,154.43
Total dividends collected	$21.6K ✓	$7.2K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: DEVLX vs ABBV ($10,000, DRIP)

Year	DEVLX Portfolio	DEVLX Income/yr	ABBV Portfolio	ABBV Income/yr	Gap
1← crossover	$12,034	$1,334.09	$11,520	$399.75	+$514.00 → DEVLX
2	$14,377	$1,500.42	$13,261	$450.98	+$1.1K → DEVLX
3	$17,059	$1,675.26	$15,255	$508.41	+$1.8K → DEVLX
4	$20,110	$1,857.69	$17,536	$572.74	+$2.6K → DEVLX
5	$23,565	$2,046.76	$20,145	$644.78	+$3.4K → DEVLX
6	$27,456	$2,241.45	$23,126	$725.38	+$4.3K → DEVLX
7	$31,818	$2,440.70	$26,532	$815.52	+$5.3K → DEVLX
8	$36,689	$2,643.48	$30,420	$916.26	+$6.3K → DEVLX
9	$42,106	$2,848.73	$34,855	$1,028.80	+$7.3K → DEVLX
10	$48,109	$3,055.45	$39,914	$1,154.43	+$8.2K → DEVLX

DEVLX vs ABBV: Complete Analysis 2026

DEVLX — Stock

The investment seeks capital appreciation. Under normal circumstances, at least 80% of the fund's net assets, plus the amount of any borrowings for investment purposes, will be in investments of small-capitalization companies. It invests primarily in investments of small companies whose stock prices, in the portfolio managers' opinion, appear low relative to their underlying value or future potential.

Full DEVLX Calculator →

ABBV — Healthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →

📬

Get this DEVLX vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DEVLX vs SCHD DEVLX vs JEPI DEVLX vs O DEVLX vs KO DEVLX vs MAIN DEVLX vs JNJ DEVLX vs MRK DEVLX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.